NIH-funded research R01 grant

Understanding how a protein called MucR helps Brucella bacteria cause illness

Official title: Determining the molecular basis of gene silencing by MucR and defining its role in Brucella virulence

Funded at East Carolina University · NIH-11111292 · Data updated 2026-11-12

This research aims to understand how a specific protein in Brucella bacteria helps them cause brucellosis, a serious infection in animals and people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEast Carolina University
NIH-funded
Lab location1 site (Greenville, United States)
Project startJuly 14, 2023
Project endJune 30, 2027
Funding year2025
Award (this year)$581,515
NIH project number5R01AI172822-03
Project IDNIH-11111292 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research does not involve direct patient participation.

Less likely to help

Patients will not receive direct benefit from participating in this laboratory-based research.

What this research studies

Brucellosis is a major health concern in many parts of the world, especially where it affects food animals. This project focuses on a protein called MucR, which is crucial for Brucella bacteria to cause disease, but we don't fully understand how it works. We believe MucR acts like a 'gene silencer,' turning off certain genes that help the bacteria survive and multiply. By studying how MucR silences these genes and how other proteins might 'counter-silence' it, we hope to learn more about how Brucella causes infection. This knowledge could lead to new ways to fight brucellosis.

Why it matters

Potential benefit: A better understanding of how Brucella causes disease could lead to the development of new treatments or vaccines for brucellosis.

How similar studies have gone: Previous work by this laboratory has provided strong evidence for MucR's role, and similar gene-silencing mechanisms are known to be important in other bacterial infections.

Where this research is happening

  • East Carolina University
    Greenville, United States
    Active

Researchers

  • Principal investigator: Roop, Roy M — East Carolina University
  • Study coordinator: Roop, Roy M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.